Cargando…
Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119238/ https://www.ncbi.nlm.nih.gov/pubmed/33177625 http://dx.doi.org/10.1038/s41417-020-00251-y |
| _version_ | 1783691831582654464 |
|---|---|
| author | Pruller, Johanna Hofer, Isabella Ganassi, Massimo Heher, Philipp Ma, Michelle T. Zammit, Peter S. |
| author_facet | Pruller, Johanna Hofer, Isabella Ganassi, Massimo Heher, Philipp Ma, Michelle T. Zammit, Peter S. |
| author_sort | Pruller, Johanna |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8119238 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81192382021-05-26 Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy Pruller, Johanna Hofer, Isabella Ganassi, Massimo Heher, Philipp Ma, Michelle T. Zammit, Peter S. Cancer Gene Ther Correction Nature Publishing Group US 2020-11-11 2021 /pmc/articles/PMC8119238/ /pubmed/33177625 http://dx.doi.org/10.1038/s41417-020-00251-y Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Pruller, Johanna Hofer, Isabella Ganassi, Massimo Heher, Philipp Ma, Michelle T. Zammit, Peter S. Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title | Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title_full | Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title_fullStr | Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title_full_unstemmed | Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title_short | Correction: A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| title_sort | correction: a human myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119238/ https://www.ncbi.nlm.nih.gov/pubmed/33177625 http://dx.doi.org/10.1038/s41417-020-00251-y |
| work_keys_str_mv | AT prullerjohanna correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy AT hoferisabella correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy AT ganassimassimo correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy AT heherphilipp correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy AT mamichellet correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy AT zammitpeters correctionahumanmyogeninpromotermodifiedtobehighlyactiveinalveolarrhabdomyosarcomadrivesaneffectivesuicidegenetherapy |